Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
Sindrom metabolik adalah masalah kesehatan yang prevalensinya cenderung meningkat pada pekerja. Penelitian ini bertujuan memaparkan prevalensi kasus sindrom metabolik yang terjadi pada pekerja perusahaan. Penelitian ini dilakukan pada tahun 2014 pada dua perusahaan di Provinsi Riau dengan rancangan potong lintang. Sumber data adalah rekam medis pekerja yang melakukan medical check up periode Oktober 2013 hingga Februari 2014. Populasi adalah pekerja yang menderita sindrom metabolik sebanyak 131 orang. Sampel penelitian dipilih dengan cara total sampling yakni 131 orang. Instrumen adalah kuesioner, international physical activity questionnaire, tabel 24 hours food recall, dan tabel bantu pencatatan komponen sindrom metabolik. Pengelolaan data dilakukan secara kuantitatif menggunakan analisis univariat dan bivariat, dengan uji korelasi Spearman?s Rho dan kai kuadrat. Hasil penelitian mendapatkan prevalensi sindrom metabolik sebanyak 21,58%, dengan jenis kelamin terbanyak adalah laki-laki, kelompok usia terbanyak adalah > 50 tahun. Sebagian besar kasus sindrom metabolik memiliki tiga komponen, dengan komponen terbanyak adalah lingkar perut dan tekanan darah. Sebanyak 23,50% kasus memiliki riwayat keluarga obesitas dan diabetes melitus. Sebagian besar kategori aktivitas adalah sedang. Jenis asupan makanan dengan kategori tidak sesuai dengan diet adalah serat pangan dan lemak jenuh. Variabel lingkar perut berhubungan bermakna secara statistik dengan tekanan darah sistolik dan diastolik serta kadar kolesterol high density lipoprotein (p < 0,05).

---

Metabolic syndrome is a health problem that often occurs among workers. The objective of this research was to reveal prevalence of metabolic syndrome in company workers. This research was conducted in 2014 at two Prevalensi Sindrom Metabolik pada Pekerja Perusahaan The Prevalence of Metabolic Syndrome among Company Workers Zahtamal*, Wasilah Rochmah**, Yayi Suryo Prabandari***, Lientje K. Setyawati**** companies in Riau Province with cross sectional design. Data source is the medical records of workers who have been doing medical check up between October 2013 through February 2014. The population is 131 workers who suffer from metabolic syndrome. The study sample is 131 workers, counted by total sampling. The instruments are self-reported questionnaire, international physical activity questionnaire, 24 hours food recall form and recording auxiliary table for components of of metabolic syndrome. Quantitative data management conducted with descriptive analysis and bivariate analysis, by Spearman?s Rho correlation test and chi square. Prevalence of metabolic syndrome is 21.58%, with the highest gender is male, and the largest age group is > 50 years. Most cases of metabolic syndrome has three components, with the largest component is the abdominal circumference and blood pressure. A total of 23.50% of cases have a family history of obesity and diabetes mellitus. Most categories of activity is moderate. Most types of food intake in the category ?out of dietary guidelines? are dietary fiber and saturated fat. Abdominal circumference variable has a statistically significant relationship with systolic and diastolic blood pressure and high density lipoprotein (p <0.05).

Abstrak :
Background: sarcopenia contributes to the development of frailty syndrome. Frailty syndrome is potentially improved by modifying insulin resistance, inflammation, and myostatin level. This study is aimed to investigate the effect of metformin on handgrip strength, gait speed, myostatin serum level, and health related quality of life (HR-QoL) among non diabetic pre frail elderly patients. Methods: a double blind randomized controlled trial study was conducted on non-diabetic elderly outpatients aged >60 years with pre frail status based on phenotype and/ or index criteria (Cardiovascular Health Study and/ or Frailty Index 40 items) consecutively recruited from March 2015 to June 2016 at Cipto Mangunkusumo Hospital. One hundred twenty subjects who met the research criteria were randomized and equally assigned into 3 x 500 mg metformin or placebo group. The study outcomes were measured at baseline and after 16 weeks of intervention. Results: out of 120 subjects, 43 subjects in metformin group and 48 subjects in placebo group who completed the intervention. There was a significant improvement on the mean gait speed of metformin group by 0.39 (0.77) second or 0.13 (0.24) meter/second that remained significant after adjusting for important prognostic factors (p = 0.024). There was no significant difference on handgrip strength, myostatin serum level, and HR QoL between both groups. Conclusion: 3 x 500 mg metformin for 16 weeks was statistically significant and clinically important in improving usual gait speed as one of the HR QoL dimensions, but did not significantly improve the EQ 5D index score, handgrip strength, nor myostatin serum level.